Bicara Therapeutics Inc (BCAX) - News Archive

In a significant stride within the realm of oncology, Bicara Therapeutics Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to its investigational therapy,...

: Bicara Therapeutics Inc. (NASDAQ: BCAX), a clinical-stage biopharmaceutical venture, is poised to present its groundbreaking work in bifunctional therapies at the upcoming Goldman Sachs 46th Annual Global Healthcare C...